faldoritinib   Click here for help

GtoPdb Ligand ID: 14628

Synonyms: Compound 204 [WO2023129667]
Compound class: Synthetic organic
Comment: Faldoritinib is the INN for a tyrosine kinase inhibitor that was included in WHO INN Proposed List 135 (July 2026). It is described as an antineoplastic agent. The structure is claimed in a number of patents for activity as a fms related receptor tyrosine kinase 3 (FLT3) inhibitor [3]. In the absence of a declared company code-to-structure, we predict that faldoritinib might be the INN for Biomea's orally bioavailable, covalent (irreversible) FLT3 inhibitor clinical lead BMF-500 [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 11
Hydrogen bond donors 3
Rotatable bonds 16
Topological polar surface area 135.73
Molecular weight 552.71
XLogP 1.06
No. Lipinski's rules broken 3

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCC1=NC(=C(NC2=CC(=CC=C2)CCNC(=O)[C@H](C)N(C)C(=O)/C=C/CN(C)C)N=C1N(C)C(C)C)C(=O)N
Isomeric SMILES N(C=1C(C(N)=O)=NC(CC)=C(N(C(C)C)C)N1)C2=CC(CCNC([C@@H](N(C(/C=C/CN(C)C)=O)C)C)=O)=CC=C2
InChI InChI=1S/C29H44N8O3/c1-9-23-28(36(7)19(2)3)34-27(25(33-23)26(30)39)32-22-13-10-12-21(18-22)15-16-31-29(40)20(4)37(8)24(38)14-11-17-35(5)6/h10-14,18-20H,9,15-17H2,1-8H3,(H2,30,39)(H,31,40)(H,32,34)/b14-11+/t20-/m0/s1
InChI Key BOKKFLKTQXTMQM-IXDOJHRFSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Bioactivity Comments
Faldoritinib is an equipotent inhibitor of wild-type FLT3 and FLT3-ITD which is a common internal tandem duplication genetic mutation found in around a quarter of acute mlyeloid leukemia patients [3]. It Does not alter KIT activity [2].Faldoritinib
Selectivity at catalytic receptors
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
fms related receptor tyrosine kinase 3 Hs Inhibitor Irreversible inhibition >10.0 pIC50 - 3
⤷ pIC50 >10.0 (IC50 <1x10-10 M) [3]
Description: Determined in a TR-FRET assay with either WY FLT3 ir FLT3-ITD